{"slideshow_credits": null, "snippet": "It may look as if Britain is trying to defend AstraZeneca from a hostile takeover by Pfizer, but in the end, market forces should be allowed to prevail.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [{"role": "reported", "rank": 1, "organization": ""}], "original": "By HUGO DIXON | REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/05/05/business/international/letting-the-market-decide-on-pfizer-astrazeneca-deal.html", "lead_paragraph": "It may look as if Britain is trying to defend AstraZeneca from a hostile takeover by Pfizer, but in the end, market forces should be allowed to prevail.", "headline": {"main": "Letting the Market Decide on Pfizer-AstraZeneca Deal", "print_headline": "Letting the Market Decide on Pfizer-AstraZeneca Deal", "content_kicker": "Political Economy"}, "_id": "536616e738f0d81bc61596b4", "word_count": "787", "multimedia": [], "pub_date": "2014-05-05T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Pfizer Inc", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "AstraZeneca PLC", "name": "organizations", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "International Business", "type_of_material": "News"}